Skip to main content
. 2021 Jan 8;70(4):932–943. doi: 10.2337/db20-0937

Table 1.

Summary of demographic and genetic data for cross-sectional and longitudinal study subjects

All Cross-sectional Longitudinal
Total N 401 382 19
Age at sample collection, years 19.5 ± 11.9 19.5 ± 11.9 20.4 ± 12.0
Age at onset, years 12.0 ± 9.1 11.9 ± 9.2 13.1 ± 5.4
T1D duration, years 7.5 ± 9.1 7.5 ± 9.0 7.2 ± 11.1
Ethnicity, n (%)
 Hispanic 41 (10.2) 41 (10.7) 0 (0)
 Non-Hispanic 329 (82) 311 (81.4) 18 (94.7)
 Not reported 31 (7.7) 30 (7.9) 1 (5.3)
Sex, n (%)
 Female 208 (51.9) 198 (51.8) 10 (52.6)
 Male 193 (48.1) 184 (48.2) 9 (47.4)
HLA status, n (%)
 DR3/3 38 (9.5) 35 (9.2) 3 (15.8)
 DR3/4 102 (25.4) 97 (25.4) 5 (26.3)
 DR3/X 65 (16.2) 63 (16.5) 2 (10.5)
 DR4/4 27 (6.7) 26 (6.8) 1 (5.3)
 DR4/X 112 (27.9) 106 (27.7) 6 (31.6)
 DRX/X 57 (14.2) 55 (14.4) 2 (10.5)
GRS 0.278 ± 0.027 0.278 ± 0.027 0.280 ± 0.023

Data are means ± SD unless otherwise indicated. All subjects were Caucasian (self-reported race) and of European descent (genetically imputed race). Of 401 subjects, 382 had one blood draw, 18 had two blood draws, and 1 had four blood draws. Notably, because all samples in this study were collected from subjects diagnosed with type 1 diabetes, GRS values are high compared with those in the general population without diabetes (3,4,22); hence, both the 80th and 20th GRS percentiles examined herein reflect “high genetic risk” for type 1 diabetes. T1D, type 1 diabetes.